Skip to main content
. 2017 Dec 26;178(5):713–715. doi: 10.1001/jamainternmed.2017.7744

Table. Characteristics of Veterans Affairs Nursing Home Hospice Patients With Type 2 Diabetes.

Patient Characteristics No. (%) P Value
All Hospice
(n = 20 329)
Not Treated With Insulin
(n = 18 642)
Treated With Insulin
(n = 1687)
Age, mean (SD), y 79 (8) 79 (8) 77 (8) <.001
Male sex 19 991 (98) 18 331 (98) 1660 (98) .80
Diagnosis
Hypertension 7746 (38) 7046 (38) 700 (42) .003
Congestive heart failure 4056 (20) 3684 (20) 372 (22) .02
Chronic kidney disease 4796 (24) 4353 (23) 443 (26) .01
Liver disease 807 (4) 750 (4) 57 (3) .20
Chronic pulmonary disease 4777 (24) 4357 (23) 420 (25) .20
Dementia 2544 (13) 2368 (13) 176 (10) .01
Cancer 7065 (35) 6434 (35) 631 (37) .02
Use of oral glucose-lowering medication 2414 (12) 2064 (11) 350 (21) <.001
Baseline glycated hemoglobin, %, mean (SD) 6.9 (1.3) 6.8 (1.3) 7.4 (1.6) <.001
No glycated hemoglobin test availablea 4058 (20) 3856 (21) 202 (12) <.001
<7.0 9364 (50) 9364 (50) 656 (39)
7.0-7.9 3192 (17) 3192 (17) 410 (24)
8.0-8.9 1281 (7) 1281 (7) 218 (13)
≥9.0 949 (5) 949 (5) 201 (12)
Death within 100 d of admission 16 791 (83) 16 791 (85) 1025 (61) <.001
Length of stay, median (IQR), d 10 (4-32) 10 (3-30) 25 (8-75) <.001
No glucose laboratory test during admission 7733 (38) 7548 (41) 185 (11) <.001
Glucose testing, mean (SD), tests/db 0.7 (1.2) 0.6 (1.1) 1.7 (1.6) <.001

Abbreviation: IQR, interquartile range.

a

Glycated hemoglobin measurements were included from 12 mo before to 3 mo after hospice admission date.

b

Glucose testing includes both point-of-care (fingerstick) and glucose laboratory testing.